{"id":"https://openalex.org/W1500346549","doi":"https://doi.org/10.4049/jimmunol.0803418","title":"Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis","display_name":"Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W1500346549","doi":"https://doi.org/10.4049/jimmunol.0803418","mag":"1500346549","pmid":"https://pubmed.ncbi.nlm.nih.gov/19414741"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.0803418","doi":"https://doi.org/10.4049/jimmunol.0803418","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.0803418","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1500346549"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034898839","display_name":"Caroline Coisne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Caroline Coisne","raw_affiliation_strings":["Theodor Kocher Institute, University of Bern , Bern, Switzerland","*Theodor Kocher Institute, University of Bern, Bern, Switzerland; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theodor Kocher Institute, University of Bern , Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]},{"raw_affiliation_string":"*Theodor Kocher Institute, University of Bern, Bern, Switzerland; and","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029495670","display_name":"Wenxian Mao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wenxian Mao","raw_affiliation_strings":["\u2020Elan Pharmaceuticals, South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020Elan Pharmaceuticals, South San Francisco, CA 94080","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069271331","display_name":"Britta Engelhardt","orcid":"https://orcid.org/0000-0003-3059-9846","observed_orcids":["https://orcid.org/0000-0003-3059-9846"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Britta Engelhardt","raw_affiliation_strings":["Theodor Kocher Institute, University of Bern , Bern, Switzerland","*Theodor Kocher Institute, University of Bern, Bern, Switzerland; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theodor Kocher Institute, University of Bern , Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]},{"raw_affiliation_string":"*Theodor Kocher Institute, University of Bern, Bern, Switzerland; and","institution_ids":["https://openalex.org/I118564535"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":6.3843,"has_fulltext":false,"cited_by_count":122,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96901189,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"182","issue":"10","first_page":"5909","last_page":"5913"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.13259999454021454,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":1.0},{"id":"https://openalex.org/keywords/integrin-alpha4","display_name":"CD49d","score":0.953000009059906},{"id":"https://openalex.org/keywords/t-cell-adhesion","display_name":"T cell adhesion","score":0.9459999799728394},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.578000009059906},{"id":"https://openalex.org/keywords/tnf-alpha-induced-inflammation","display_name":"TNF-\u03b1-induced inflammation","score":0.7519999742507935},{"id":"https://openalex.org/keywords/intravital-microscopy","display_name":"intravital microscopy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/anti-adhesion-therapy","display_name":"anti-adhesion therapy","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.9777645468711853},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8310428857803345},{"id":"https://openalex.org/C2778486448","wikidata":"https://www.wikidata.org/wiki/Q494066","display_name":"Experimental autoimmune encephalomyelitis","level":3,"score":0.7130670547485352},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.5522567629814148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5235419273376465},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.514517068862915},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.4868890345096588},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4840218722820282},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4226170480251312},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3204469680786133},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.23116356134414673},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1696884036064148},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13304975628852844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.05742242932319641},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002634","descriptor_name":"Chemotaxis, Leukocyte","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004681","descriptor_name":"Encephalomyelitis, Autoimmune, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008856","descriptor_name":"Microscopy, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D036904","descriptor_name":"Leukocyte Rolling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.4049/jimmunol.0803418","doi":"https://doi.org/10.4049/jimmunol.0803418","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.0803418","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:19414741","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19414741","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Journal Article"},{"id":"pmh:oai:boris.unibe.ch:32144","doi":null,"is_oa":false,"landing_page_url":"https://boris.unibe.ch/32144/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401086","display_name":"Bern Open Repository and Information System (University of Bern)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118564535","host_organization_name":"University of Bern","host_organization_lineage":["https://openalex.org/I118564535"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Coisne, Caroline; Mao, Wenxian; Engelhardt, Britta (2009). Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. Journal of immunology, 182(10), pp. 5909-13. Bethesda, Md.: American Association of Immunologists 10.4049/jimmunol.0803418 &lt;http://dx.doi.org/10.4049/jimmunol.0803418&gt;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320322202","display_name":"IC Design Education Center","ror":"https://ror.org/005v57z85"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1514064771","https://openalex.org/W1980661152","https://openalex.org/W1996722399","https://openalex.org/W2003793322","https://openalex.org/W2019582599","https://openalex.org/W2020964731","https://openalex.org/W2051256636","https://openalex.org/W2092002465","https://openalex.org/W2095141538","https://openalex.org/W2103758700","https://openalex.org/W2127198284","https://openalex.org/W2130277789","https://openalex.org/W2135644109","https://openalex.org/W2149431167","https://openalex.org/W2165149508","https://openalex.org/W2348344749","https://openalex.org/W2425879905"],"related_works":["https://openalex.org/W4377821431","https://openalex.org/W2024898420","https://openalex.org/W2092002465","https://openalex.org/W2004832585","https://openalex.org/W2104195747","https://openalex.org/W2277927575","https://openalex.org/W2551047548","https://openalex.org/W2165756416","https://openalex.org/W1993850633"],"abstract_inverted_index":{"The":[0,88],"humanized":[1],"anti-alpha(4)":[2],"integrin":[3],"Ab":[4],"Natalizumab":[5,14],"is":[6,15,132],"an":[7],"effective":[8,106],"treatment":[9],"for":[10],"relapsing-remitting":[11],"multiple":[12,152],"sclerosis.":[13,153],"thought":[16],"to":[17,32,92,97,103,126],"exert":[18],"its":[19,48],"therapeutic":[20],"efficacy":[21],"by":[22,135],"blocking":[23],"the":[24,33,63,68,77,98,127,140],"alpha(4)":[25,38,119],"integrin-mediated":[26,120],"binding":[27],"of":[28,54,72,90,122,146,148],"circulating":[29],"immune":[30],"cells":[31,75,125],"blood-brain":[34],"barrier":[35],"(BBB).":[36],"As":[37],"integrins":[39],"control":[40],"other":[41],"immunological":[42],"processes,":[43],"natalizumab":[44,60,91,136],"may,":[45],"however,":[46],"execute":[47],"beneficial":[49],"effects":[50],"elsewhere.":[51],"By":[52],"means":[53],"intravital":[55],"microscopy":[56],"we":[57],"demonstrate":[58,117],"that":[59,118],"specifically":[61],"inhibits":[62],"firm":[64],"adhesion":[65,96,121],"but":[66],"not":[67],"rolling":[69],"or":[70],"capture":[71],"human":[73,123],"T":[74,94,124],"on":[76],"inflamed":[78,99,128],"BBB":[79,100,129],"in":[80,107,110,143,151],"mice":[81],"with":[82],"acute":[83,111],"experimental":[84],"autoimmune":[85],"encephalomyelitis":[86],"(EAE).":[87],"efficiency":[89],"block":[93],"cell":[95],"was":[101],"found":[102],"be":[104],"more":[105],"EAE":[108,131],"than":[109],"systemic":[112],"TNF-alpha-induced":[113],"inflammation.":[114],"Our":[115],"data":[116],"during":[130],"efficiently":[133],"blocked":[134],"and":[137],"thus":[138],"provide":[139],"first":[141],"direct":[142],"vivo":[144],"proof":[145],"concept":[147],"this":[149],"therapy":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1500346549","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
